Company intelligence / Profile preview
Deinove
Grabels, Occitania, Francelive.euronext.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 2
01
Overview
Deinove developed a proprietary platform to discover new antibiotics from rare/extremophile bacteria. Its lead program DNV3837 reached Phase II trials in severe C. difficile infection but there are no recent updates on successful completion or further clinical progress. The company also developed cosmetic actives and animal feed ingredients using its microbial technology.
- Therapeutic areas
- OtherDermatologyInfectious Diseases
- Modalities
- Small molecules (antibiotics and other microbial-derived compounds)Natural ingredients for cosmetics and nutritionBacterial micro-factories for compound production
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
bioMérieuxNaiconsMedpaceInstitut PasteurHallstar Group/Oléos-Hallstar/Greentech/Sharon Laboratories/Avril Group [primarily R&D/commercialization partnerships].
Beyond the preview
Go deeper on Deinove.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Deinove.